Edit |   |
---|---|
Antigenic Specificity | CD49a, Mouse/Rat |
Clone | REA493 |
Host Species | Recombinant Human |
Reactive Species | mouse, rat |
Isotype | IgG1 |
Format | APC-Vio 770 conjugate |
Size | 30 µg in 200 µL |
Concentration | 1:50 |
Applications | Flow cytometry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD49a Antibody, anti-mouse/rat, APC-Vio® 770, REAfinity™. Clone REA493 recognizes the mouse and rat CD49a antigen, a 180 kDa single-pass type I membrane protein also known as integrin α1 (Itga1). CD49a binds to CD29 (integrin β1) to form the heterodimeric integrin very late antigen 1 (VLA-1), which has been found to be widely expressed on various cell types, including mesenchymal cells, epithelial cells, macrophages, NKT cells, and T cells. VLA-1 is a receptor for laminin and collagen and interacts, via the I-domain of the extracellular domain of the CD49a subunit, with collagen molecules in the extracellular matrix. CD49a expression parallels high levels of IFN-γ production in effector T cells, and CD49a has been intensively studied for its role in mediating T-cell accumulation, apoptosis, and retention within pathological tissues in immune-mediated inflammation. | Additional information: Clone REA493 displays negligible binding to Fc receptors. |
Immunogen | n/a |
Other Names | Itga1, VLA-1 |
Gene, Accession # | Gene ID: 25118, 109700 |
Catalog # | 130-125-104 |
Price | $162 |
Order / More Info | CD49a, Mouse/Rat Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Ben-Horin, S. et al. (2004) The role of very late antigen-1 in immune-mediated inflammation. Clin. Immunol. 113 (2): 119-129. | Chen, Y. et al. (2014) CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production. Immunology 141 (3): 388-400. | Gindraux, F. et al. (2007) Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res. 327 (3): 471-483. |